(NEDAP) NV Nederlandsche - Ratings and Ratios
Software, Healthcare, Livestock, Retail, Security, Electronic Equipment
Description: NEDAP NV Nederlandsche
Nedap N.V. is a diversified technology company operating in multiple sectors including healthcare, livestock, retail, and security. The company develops and manufactures electronic equipment and software, providing a range of innovative solutions to its clients. Its healthcare software services, such as Nedap MediKIT and Caren, aim to streamline clinical workflows and improve patient care.
In the livestock sector, Nedaps sensor-based cow monitoring and management solutions, including Nedap FarmControl and CowControl, provide farmers with real-time insights into cow health and fertility, enhancing farm operations. The companys retail solutions, such as Nedap iD Cloud and Sense, utilize RFID technology to improve inventory management and loss prevention. Additionally, Nedaps security solutions, including Nedap Access and Pace, offer advanced access control and security insights.
From a financial perspective, Nedaps market capitalization stands at approximately €452.63 million, with a price-to-earnings ratio of 24.36, indicating a relatively stable valuation. The companys return on equity (RoE) is 37.45%, suggesting a strong ability to generate profits from shareholder equity. To further evaluate Nedaps performance, key performance indicators (KPIs) such as revenue growth, operating margin, and debt-to-equity ratio can be analyzed. For instance, a high revenue growth rate and operating margin would indicate Nedaps ability to expand its business and maintain profitability.
Some additional KPIs that can be used to assess Nedaps performance include its gross margin, which can indicate the companys pricing power and cost management; its research and development (R&D) expenditure as a percentage of revenue, which can highlight its commitment to innovation; and its dividend yield, which can attract income-seeking investors. By analyzing these KPIs, investors can gain a more comprehensive understanding of Nedaps financial health and growth prospects.
NEDAP Stock Overview
| Market Cap in USD | 695m |
| Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
NEDAP Stock Ratings
| Growth Rating | 94.2% |
| Fundamental | 85.0% |
| Dividend Rating | 73.7% |
| Return 12m vs S&P 500 | 37.9% |
| Analyst Rating | - |
NEDAP Dividends
| Dividend Yield 12m | 4.32% |
| Yield on Cost 5y | 9.62% |
| Annual Growth 5y | 7.30% |
| Payout Consistency | 87.9% |
| Payout Ratio | 99.4% |
NEDAP Growth Ratios
| Growth Correlation 3m | 96.9% |
| Growth Correlation 12m | 91.3% |
| Growth Correlation 5y | 84.9% |
| CAGR 5y | 21.72% |
| CAGR/Max DD 5y | 1.06 |
| Sharpe Ratio 12m | -0.17 |
| Alpha | 56.69 |
| Beta | 0.426 |
| Volatility | 17.85% |
| Current Volume | 8.2k |
| Average Volume 20d | 10.4k |
| Stop Loss | 87.6 (-3.1%) |
| Signal | -1.60 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (29.8m TTM) > 0 and > 6% of Revenue (6% = 22.8m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 11.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.05% (prev 21.80%; Δ -10.75pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.37 (>3.0%) and CFO 51.4m > Net Income 29.8m (YES >=105%, WARN >=100%) |
| Net Debt (9.94m) to EBITDA (58.1m) ratio: 0.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (6.55m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 22.56% (prev 22.92%; Δ -0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 274.0% (prev 155.8%; Δ 118.2pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 45.55 (EBITDA TTM 58.1m / Interest Expense TTM 948.0k) >= 6 (WARN >= 3) |
Altman Z'' 4.90
| (A) 0.31 = (Total Current Assets 79.0m - Total Current Liabilities 36.9m) / Total Assets 137.4m |
| (B) 0.13 = Retained Earnings (Balance) 18.5m / Total Assets 137.4m |
| (C) 0.31 = EBIT TTM 43.2m / Avg Total Assets 138.9m |
| (D) 0.35 = Book Value of Equity 18.5m / Total Liabilities 53.7m |
| Total Rating: 4.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.99
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 3.36% = 1.68 |
| 3. FCF Margin 5.35% = 1.34 |
| 4. Debt/Equity 0.17 = 2.49 |
| 5. Debt/Ebitda 0.25 = 2.45 |
| 6. ROIC - WACC 30.81% = 12.50 |
| 7. RoE 37.45% = 2.50 |
| 8. Rev. Trend 96.44% = 4.82 |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend 68.49% = 1.71 |
| 11. EPS CAGR 27.66% = 2.50 |
What is the price of NEDAP shares?
Over the past week, the price has changed by -0.55%, over one month by +4.51%, over three months by +45.10% and over the past year by +61.26%.
Is NV Nederlandsche a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NEDAP is around 107.54 EUR . This means that NEDAP is currently undervalued and has a potential upside of +18.96% (Margin of Safety).
Is NEDAP a buy, sell or hold?
What are the forecasts/targets for the NEDAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 85 | -6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 118.8 | 31.4% |
NEDAP Fundamental Data Overview
Market Cap EUR = 596.3m (596.3m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 4.36m EUR (Cash only, last quarter)
P/E Trailing = 27.9876
P/S = 2.2721
P/B = 8.1853
Beta = 0.405
Revenue TTM = 380.6m EUR
EBIT TTM = 43.2m EUR
EBITDA TTM = 58.1m EUR
Long Term Debt = 14.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 300.0k EUR (from shortLongTermDebt, last quarter)
Debt = 14.3m EUR (Calculated: Short Term 300.0k + Long Term 14.0m)
Net Debt = 9.94m EUR (from netDebt column, last quarter)
Enterprise Value = 606.2m EUR (596.3m + Debt 14.3m - CCE 4.36m)
Interest Coverage Ratio = 45.55 (Ebit TTM 43.2m / Interest Expense TTM 948.0k)
FCF Yield = 3.36% (FCF TTM 20.4m / Enterprise Value 606.2m)
FCF Margin = 5.35% (FCF TTM 20.4m / Revenue TTM 380.6m)
Net Margin = 7.84% (Net Income TTM 29.8m / Revenue TTM 380.6m)
Gross Margin = 22.56% ((Revenue TTM 380.6m - Cost of Revenue TTM 294.7m) / Revenue TTM)
Tobins Q-Ratio = 32.72 (Enterprise Value 606.2m / Book Value Of Equity 18.5m)
Interest Expense / Debt = 3.01% (Interest Expense 431.0k / Debt 14.3m)
Taxrate = 15.35% (from quarterly Income Tax Expense: 1.66m / 10.8m)
NOPAT = 36.6m (EBIT 43.2m * (1 - 15.35%))
Current Ratio = 2.14 (Total Current Assets 79.0m / Total Current Liabilities 36.9m)
Debt / Equity = 0.17 (Debt 14.3m / last Quarter total Stockholder Equity 83.7m)
Debt / EBITDA = 0.25 (Net Debt 9.94m / EBITDA 58.1m)
Debt / FCF = 0.70 (Debt 14.3m / FCF TTM 20.4m)
Total Stockholder Equity = 79.7m (last 4 quarters mean)
RoA = 21.73% (Net Income 29.8m, Total Assets 137.4m )
RoE = 37.45% (Net Income TTM 29.8m / Total Stockholder Equity 79.7m)
RoCE = 46.09% (Ebit 43.2m / (Equity 79.7m + L.T.Debt 14.0m))
RoIC = 38.27% (NOPAT 36.6m / Invested Capital 95.5m)
WACC = 7.46% (E(596.3m)/V(610.6m) * Re(7.58%)) + (D(14.3m)/V(610.6m) * Rd(3.01%) * (1-Tc(0.15)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.39%
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈14.3m ; Y1≈17.7m ; Y5≈30.2m
Fair Price DCF = 77.91 (DCF Value 513.3m / Shares Outstanding 6.59m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 96.44 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: 3.63
EPS Correlation: 68.49 | EPS CAGR: 27.66%
EPS Growth-of-Growth: -19.24